|
|
Article: Experimental Anti-cancer Agent Phenoxodiol Induces Death of Chemo-resistant Ovarian Cancer Cells; Yale Researchers Identify Significant New Signaling Pathways for Ovarian Cancer and Confirm Phenoxodiol's Ability to Successfully Alter Signals to Induce Cancer Cell Death.
- Article from:
- PR Newswire
- Article date:
- April 4, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Laboratory-based data confirming that phenoxodiol causes chemo-resistant ovarian cancer cells to die are published in the proceedings of the 94th annual meeting of the American Association for Cancer Research. Researchers at Yale School of Medicine who conducted the study also found two signaling pathways that regulate ovarian cancer cells, indicating that phenoxodiol works by altering the signals made by these pathways.
The data were also presented last week at the 50th annual scientific meeting of the Society for Gynecologic Investigation in Washington, D.C.
Phenoxodiol is an experimental anti-cancer drug manufactured by Novogen, Limited {Nasdaq: ...